Literature DB >> 21584286

Altered oxidative stress levels in Indian Parkinson's disease patients with PARK2 mutations.

Monika Vinish1, Akshay Anand, Sudesh Prabhakar.   

Abstract

The aim of this pilot study was to determine the baseline state of oxidative stress indices in patients with Parkinson's disease (PD). Peripheral blood samples of 15 PD subjects were analyzed and compared with ten age matched healthy controls. Patients with PARK2 mutations were also compared with PD patients without mutations. There was significant increase in malondialdehyde content and superoxide-dismutase (SOD) activity in peripheral blood parameters in PD patients (p < 0.05) in comparison to controls. These findings suggest an important role of oxidative stress in Parkinson's disease evolution and progress. No changes were observed in glutathione peroxidase and nitric oxide levels. We found significant correlation between SOD activity and lipid peroxidation when the biochemical data was further analyzed. In addition, significant increase in the levels of SOD among the PD patients with PARK2 mutations was observed, which can be ascribed to chronic oxidative stress induced by PARK2 mutations.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21584286

Source DB:  PubMed          Journal:  Acta Biochim Pol        ISSN: 0001-527X            Impact factor:   2.149


  21 in total

Review 1.  Disturbance of redox homeostasis as a contributing underlying pathomechanism of brain and liver alterations in 3-hydroxy-3-methylglutaryl-CoA lyase deficiency.

Authors:  Guilhian Leipnitz; Carmen Regla Vargas; Moacir Wajner
Journal:  J Inherit Metab Dis       Date:  2015-06-04       Impact factor: 4.982

2.  Surprising behavioral and neurochemical enhancements in mice with combined mutations linked to Parkinson's disease.

Authors:  Meghan R Hennis; Marian A Marvin; Charles M Taylor; Matthew S Goldberg
Journal:  Neurobiol Dis       Date:  2013-09-26       Impact factor: 5.996

Review 3.  Oxidative stress-induced signaling pathways implicated in the pathogenesis of Parkinson's disease.

Authors:  Georgia S Gaki; Athanasios G Papavassiliou
Journal:  Neuromolecular Med       Date:  2014-02-13       Impact factor: 3.843

Review 4.  Exosomal miRNAs in central nervous system diseases: biomarkers, pathological mediators, protective factors and therapeutic agents.

Authors:  Xiaohuan Xia; Yi Wang; Yunlong Huang; Han Zhang; Hongfang Lu; Jialin C Zheng
Journal:  Prog Neurobiol       Date:  2019-09-19       Impact factor: 11.685

Review 5.  The bad, the good, and the ugly about oxidative stress.

Authors:  Marlene Jimenez-Del-Rio; Carlos Velez-Pardo
Journal:  Oxid Med Cell Longev       Date:  2012-04-26       Impact factor: 6.543

Review 6.  Oxidative stress in genetic mouse models of Parkinson's disease.

Authors:  Mustafa Varçin; Eduard Bentea; Yvette Michotte; Sophie Sarre
Journal:  Oxid Med Cell Longev       Date:  2012-07-08       Impact factor: 6.543

7.  Bax modulates neuronal survival while p53 is unaltered after Cytochrome C induced oxidative stress in the adult olfactory bulb in vivo.

Authors:  Olalekan M Ogundele; Olurotimi J Sanya
Journal:  Ann Neurosci       Date:  2015-01

8.  Behavioral and neurotransmitter abnormalities in mice deficient for Parkin, DJ-1 and superoxide dismutase.

Authors:  Meghan R Hennis; Katherine W Seamans; Marian A Marvin; Bradford H Casey; Matthew S Goldberg
Journal:  PLoS One       Date:  2013-12-26       Impact factor: 3.240

Review 9.  Role of early life exposure and environment on neurodegeneration: implications on brain disorders.

Authors:  Shweta Modgil; Debomoy K Lahiri; Vijay L Sharma; Akshay Anand
Journal:  Transl Neurodegener       Date:  2014-04-29       Impact factor: 8.014

Review 10.  Shared mechanisms of neurodegeneration in Alzheimer's disease and Parkinson's disease.

Authors:  Anmu Xie; Jing Gao; Lin Xu; Dongmei Meng
Journal:  Biomed Res Int       Date:  2014-05-12       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.